Physician profile
Farshid Rahbar
NPI 1780606061
$10,175.57
in general payments reported to CMS, 2019-2025
8 companies · $32.48 in 2025
The $32.48 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $58.35 · 2020: $9,522 · 2021: $39.52 · 2022: $201 · 2023: $278 · 2024: $43.83 · 2025: $32.48.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $354.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Romark Laboratories, Lc | $9,506.55 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $233.72 | 2019-2022 | |
| Ardelyx, INC. | $177.41 | 2023-2024 | Ibsrela |
| Perspectum Diagnostics Ltd | $144.32 | 2023 | Livermultiscan |
| Abbvie INC. | $41.04 | 2019 | |
| Capsovision, INC. | $32.48 | 2025 | Capsocam Plus |
| Ironwood Pharmaceuticals, INC | $28.00 | 2022 | |
| Redhill Biopharma INC. | $12.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farshid Rahbar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.